logo-loader

Matinas BioPharma CEO says company is beating out competitor for reducing serum triglycerides

Published: 11:44 01 Oct 2018 EDT

Matinas BioPharma Holdings Inc (NYSE:MTNB) CEO Jerry Jabbour speaks to Proactive's Christine Corrado at the MicroCap Conference in New York.

Matinas BioPharma is a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its LNC platform technology. The Company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic and orally bioavailable.

ARway.ai announces multiple new SaaS developer contracts in both the United...

ARway.ai (CSE:ARWY, OTCQB:ARWYF) Chief Executive Officer Evan Gappelberg joined Steve Darling from Proactive to announce multiple new SaaS developer sign-ups for its augmented reality experience platform, focusing on AR indoor navigation. These partnerships represent significant milestones in...

41 minutes ago